Alegría-Landa Victoria, Jo-Velasco Margarita, Santonja Carlos, Eraña Itziar, Vergara-Sanchez Aranzazú, Kutzner Heinz, Requena Luis
Department of Dermatology, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.
Department of Pathology, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.
J Cutan Pathol. 2020 Jan;47(1):12-16. doi: 10.1111/cup.13572. Epub 2019 Sep 4.
The association of syringocystadenoma papilliferum (SCAP) with verrucous carcinoma (VC) of the skin in the same lesion is a rare, but well-documented event. Although human papillomaviruses (HPV) have been proposed to have an etiologic role in the development of the verrucous proliferations associated with SCAP, most of the immunohistochemical and molecular studies have failed to show the presence of their genomic material in these lesions. We report a series of four cases of SCAP associated with VC in anogenital lesions. In two of the cases, we demonstrated the presence of the BRAF mutation by polymerase chain reaction and immunohistochemistry, both in the glandular and in the squamous component. No HPV-related histopathologic changes were found, nor could the presence of viral DNA be showed.
皮肤中同一病变内的乳头状汗腺囊腺瘤(SCAP)与疣状癌(VC)相关联是一种罕见但有充分文献记载的情况。尽管有人提出人乳头瘤病毒(HPV)在与SCAP相关的疣状增生的发生中起病因学作用,但大多数免疫组织化学和分子研究未能在这些病变中显示其基因组物质的存在。我们报告了一系列4例发生于肛门生殖器病变的SCAP与VC相关的病例。在其中2例病例中,我们通过聚合酶链反应和免疫组织化学在腺性和鳞状成分中均证实了BRAF突变的存在。未发现与HPV相关的组织病理学变化,也未显示病毒DNA的存在。